Latest news with #CarolMassar
Bloomberg
20 hours ago
- Business
- Bloomberg
AstraZeneca's US Investment, Future of Psychedelic Therapy
On today's episode of Bloomberg Businessweek Daily with Tim Stenovec and Carol Massar, Pascal Soriot, Chief Executive Officer of AstraZeneca discusses the company's quarterly earnings. Kabir Nath, Chief Executive Officer of Compass Pathways, on the pursuit of FDA approval of the first psychedelic treatment for certain people living with depression. Also, Bloomberg's Molly Smith and Oliver Crook on US-China Trade talks and the FOMC meeting (Source: Bloomberg)
Bloomberg
2 days ago
- Business
- Bloomberg
Bloomberg Businessweek Daily 7/28/2025
On today's episode of Bloomberg Businessweek Daily, Carol Massar and Tim Stenovec discuss the latest from President Trump's trip to Scotland. They also spoke with the CEO of the Dallas Mavericks about the franchise's future and the WNBA. (Source: Bloomberg)
Bloomberg
09-07-2025
- Business
- Bloomberg
Equities Hold Gains Ahead Close
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Caroline Hyde, Carol Massar and Tim Stenovec. (Source: Bloomberg)
Bloomberg
02-07-2025
- Business
- Bloomberg
S&P 500 Logs Fresh Record High
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Scarlet Fu, Carol Massar and Matt Miller. (Source: Bloomberg)
Bloomberg
02-07-2025
- Business
- Bloomberg
MARA's Thiel Sees Huge Institutional Interest in Bitcoin
MARA CEO Fred Thiel discusses the demand for crypto, the state of the Bitcoin-mining industry and MARA's business strategy with Carol Massar and Matt Miller on Bloomberg Television. (Source: Bloomberg)
